Drug Database
Back to search

Norway· NO-ID_A55EC98F-EC6D-40E8-893F-9F1478518EF3

Deltyba

A delamanid product containing delamanid, registered in Norway by Otsuka. The same ATC class is registered in 12 of our 19 countries.

ATC J04AK06

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedDeltybaATCJ04AK06REGISTER NO.NO-ID_A55EC98F-EC6D-4…PACKS LISTED2CHECKEDOctober 2, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about delamanidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Delamanid is registered in 12 of 19 countries.

Countries holding a registration under ATC J04AK06 (delamanid), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose
Search delamanid products by name

Delamanid · ATC J04AK06

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Delamanid
Manufacturer
Otsuka
Country
Norway (NO)
ATC code
J04AK06
ATC class
Delamanid
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
October 2, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_A55EC98F-EC6D-40E8-893F-9F1478518EF3
  • no_varenummer
    295394
    48

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Delamanid in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All delamanid products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Deltyba
  • Liechtenstein · Deltyba

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/84a8658c-74ef-4b6b-9a28-b51743d1d196
GET /v1/drugs/84a8658c-74ef-4b6b-9a28-b51743d1d196?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Delamanid",
  "merkevare_id": "ID_A55EC98F-EC6D-40E8-893F-9F1478518EF3",
  "name_form_strength": "Deltyba tab 50 mg",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about delamanid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console